treatment of Duchenne muscular dystrophy
All entries for: Atossa Therapeutics, Inc.
January 15, 2026
Atossa Therapeutics, Inc.
Orphan Drug Designation
Disease Area: Rare Disease
treatment of Duchenne muscular dystrophy